NR4A1 and breast carcinoma: This notion obtains support from a meta-analysis of four RCTs with 4050 breast cancer survivors, which associates HRT with cancer recurrence in patients with hormone-receptor-positive tumors but not in those with hormone-receptor-negative disease [35].